These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23283744)

  • 1. Down-regulation of the ErbB3 binding protein 1 in human bladder cancer promotes tumor progression and cell proliferation.
    He HC; Ling XH; Zhu JG; Fu X; Han ZD; Liang YX; Deng YH; Lin ZY; Chen G; Chen YF; Mo RJ; Zhong WD
    Mol Biol Rep; 2013 May; 40(5):3799-805. PubMed ID: 23283744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The downregulation of ErbB3 binding protein 1 (EBP1) is associated with poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Hu B; Xiong Y; Ni R; Wei L; Jiang D; Wang G; Wu D; Xu T; Zhao F; Zhu M; Wan C
    Mol Cell Biochem; 2014 Nov; 396(1-2):175-85. PubMed ID: 25081333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. QKI-6 inhibits bladder cancer malignant behaviours through down-regulating E2F3 and NF-κB signalling.
    Shi F; Deng Z; Zhou Z; Jiang CY; Zhao RZ; Sun F; Cui D; Bei XY; Yang BY; Sun Q; Wang XJ; Wu Q; Xia SJ; Han BM
    J Cell Mol Med; 2019 Oct; 23(10):6578-6594. PubMed ID: 31449345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance.
    Zhang Y; Linn D; Liu Z; Melamed J; Tavora F; Young CY; Burger AM; Hamburger AW
    Mol Cancer Ther; 2008 Oct; 7(10):3176-86. PubMed ID: 18852121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ebp1 p48 promotes oncogenic properties in hepatocellular carcinoma through p38 MAPK/HIF1α activation and p53 downregulation.
    Bao Y; Suvesh M; Li X; Bai X; Li H; Li X; Xu D; Liu L
    Mol Carcinog; 2021 Apr; 60(4):252-264. PubMed ID: 33634940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of Ebp1 and p53 protein expression in cervical cancer.
    Liu L; Li XD; Chen HY; Cui JS; Xu DY
    Genet Mol Res; 2015 Oct; 14(4):11860-6. PubMed ID: 26436510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of heregulin mediated MCF-7 breast cancer cell growth by the ErbB3 binding protein EBP1.
    Zhang Y; Akinmade D; Hamburger AW
    Cancer Lett; 2008 Jul; 265(2):298-306. PubMed ID: 18355957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ebp1 p48 promotes oncogenic activities in human colon cancer cells through regulation of TIF-90-mediated ribosomal RNA synthesis.
    Nguyen DQ; Hoang DH; Nguyen TTV; Ho HD; Huynh V; Shin JH; Ly QT; Thi Nguyen DD; Ghoda L; Marcucci G; Nguyen LXT
    J Cell Physiol; 2019 Aug; 234(10):17612-17621. PubMed ID: 30793766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High expression of ErbB3 binding protein 1 (EBP1) predicts poor prognosis of pancreatic ductal adenocarcinoma (PDAC).
    Gong C; Zhang Y; Chen Y; Zhang H; Liu X; Xue H; Ji L; Wang L; Yang L; Zhou G; Wan C
    Tumour Biol; 2015 Dec; 36(12):9189-99. PubMed ID: 26088450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ErbB3-binding protein EBP1 modulates lapatinib sensitivity in prostate cancer cells.
    Awasthi S; Ezelle H; Hassel BA; Hamburger AW
    Mol Cell Biochem; 2015 Jul; 405(1-2):177-86. PubMed ID: 25876877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of ERBB3 binding protein 1 (EBP1) in salivary adenoid cystic carcinoma and its clinicopathological relevance.
    Sun J; Luo Y; Tian Z; Gu L; Xia SC; Yu Y
    BMC Cancer; 2012 Oct; 12():499. PubMed ID: 23110497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EBP1 suppresses growth, migration, and invasion of thyroid cancer cells through upregulating RASAL expression.
    Liu H; Li Z; Li L; Peng H; Zhang Z
    Tumour Biol; 2015 Nov; 36(11):8325-31. PubMed ID: 26008146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and Role of the ErbB3-Binding Protein 1 in Acute Myelogenous Leukemic Cells.
    Nguyen le XT; Zhu L; Lee Y; Ta L; Mitchell BS
    Clin Cancer Res; 2016 Jul; 22(13):3320-7. PubMed ID: 26813358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression and prognostic role of EBP1 and relationship with AR in HER2+ breast cancer.
    Liu J; Xu C; Xu D; Cao L; Xue H; Meng Q; Niu Y
    Virchows Arch; 2020 Aug; 477(2):279-289. PubMed ID: 32086588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of the ErbB3 binding protein Ebp1 by p21-activated kinase 1 in breast cancer cells.
    Akinmade D; Talukder AH; Zhang Y; Luo WM; Kumar R; Hamburger AW
    Br J Cancer; 2008 Mar; 98(6):1132-40. PubMed ID: 18283314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ebp1 protein expression in cervical cancer tissue and its significance.
    Liu L; Xu DY; Yang SS; Li XD
    Genet Mol Res; 2015 May; 14(2):5496-500. PubMed ID: 26125746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel Anxa2-interacting protein Ebp1 inhibits cancer proliferation and invasion by suppressing Anxa2 protein level.
    Zhang F; Liu Y; Wang Z; Sun X; Yuan J; Wang T; Tian R; Ji W; Yu M; Zhao Y; Niu R
    Mol Cell Endocrinol; 2015 Aug; 411():75-85. PubMed ID: 25917452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ErbB3 binding protein 1 (EBP1) participates in the regulation of intestinal inflammation via mediating Akt signaling pathway.
    Miao X; Tang Q; Miao X; Wu Y; Qian J; Zhao W; Wang L; Li L; Zhang D
    Mol Immunol; 2015 Oct; 67(2 Pt B):540-51. PubMed ID: 26256794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor (AR) inhibitor ErbB3-binding protein-1 (Ebp1) is not targeted by the newly identified AR controlling signaling axis heat-shock protein HSP27 and microRNA miR-1 in prostate cancer cells.
    Stope MB; Peters S; Großebrummel H; Zimmermann U; Walther R; Burchardt M
    World J Urol; 2015 Mar; 33(3):323-7. PubMed ID: 24798454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer.
    Zhang Y; Ali TZ; Zhou H; D'Souza DR; Lu Y; Jaffe J; Liu Z; Passaniti A; Hamburger AW
    Cancer Res; 2010 Jan; 70(1):240-8. PubMed ID: 20048076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.